The project is aligned with the WHO “Neurology and COVID-19 Global Forum” which aims to enable harmonized approaches to clinical management, surveillance and research on neurological disorders in the context of the COVID-19 pandemic. This study will recruit approximately 500 subjects, aged 45 and older from NUH over a period of 1.5 years. Older adults from the community may be invited to join the study through referrals by existing participants/word of mouth/MACC website.

What do I need to participate?

You qualify for WWFINGER COVID-19 if you:

• Are aged 45 or above.
• Have not been diagnosed with dementia.
• Are able to give consent.

I fulfill the requirements above and I want to participate, what do I do next?

During the first contact, approximately 15 minutes will be taken to explain the study to you in detail including procedures, risks, benefits, alternatives to participants and answer any question that you have.

What will I do as a participant?

If you agree to take part in this study, your written consent to participate in this study will be obtained. You will be asked to complete a one-time survey questionnaire through phone call, online form or face-to-face session, which will take approximately 45 minutes. This study is not meant for surveillance of the participants (e.g., it is not meant to identify or report to the authority individuals who do not respect governmental orders related to the COVID-19 pandemic). The survey is anonymous; respondents’ identities are kept private even after they answer all its questions.

What are the benefits of participating?

• You will contribute to achieve a better understanding of the impact of COVID-19 on lifestyle and wellbeing.

If you want to participate, please contact the study coordinator